What is Changchun High-Tech Industry (Group) Co., Ltd.'s (000661.SZ) StockRank?

MoatMap's StockRank for Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) is 34/100, with a Sell signal. This is a composite score combining Quality (50), Value (32), and Momentum (40) factor ranks across MoatMap's 20,000+ stock universe.

Does Changchun High-Tech Industry (Group) Co., Ltd. have an economic moat?

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Changchun High-Tech Industry (Group) Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) is Sell, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Changchun High-Tech Industry (Group) Co., Ltd. in?

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

000661.SZ

Sell

Changchun High-Tech Industry (Group) Co., Ltd. · Healthcare · China · $4.8B · Avg Vol: $123M/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-2.0%

D/E

0.1x

Dividend %

0.2%

COMPANY DESCRIPTION

Changchun High-Tech Industry (Group) is a leading biopharmaceutical company, best known for its subsidiary GeneScience Pharmaceuticals, which dominates China's recombinant human growth hormone (rhGH) market. The company enjoys a near-monopoly position in the domestic pediatric growth hormone segment, yielding exceptionally high gross margins and strong cash generation. It stands as a premier high-growth biotech leader with expanding pipelines in vaccines and oncology.

FINANCIAL SUMMARY (CNY)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	12.6B	14.6B	13.5B	12.1B	-1.5%	11.0B	11.6B	12.6B	2.1%
EPS (CNY)	10.29	11.21	6.42	0.39	-66.4%	-0.87	—	—	—
Shares	404.7M	404.7M	408.0M	407.9M	+0.8%	407.9M	—	—	—
Debt	1.4B	1.5B	1.6B	1.9B	10.2%	2.3B	—	—	—
Equity	18.0B	22.1B	23.0B	22.0B	6.8%	—	—	—	—
Op CF	2.8B	5.1B	3.1B	802.1M	-34.3%	1.3B	—	—	—
Inv CF	-2.3B	-2.3B	-2.4B	-3.8B	—	—	—	—	—
Fin CF	-776.2M	-740.0M	-2.2B	-906.0M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+5.5%

SMA 50SMA 200

$11.41

RSI (14)

43.7

52W High

$21.05

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

0.2%47.1

ROE

-2.0%44.1

GP/Assets

29.2%64.3

Op. Margin

13.0%70.9

FCF/Assets

-4.7%36.8

Piotroski

431.4

Int. Cover

1.0x40.9

D/E Ratio

0.09x63.6

Current Ratio

2.97x53.6

Value

P/E (TTM)

—N/A

EV/EBITDA

29.1x20.5

P/FCF

—N/A

P/B

1.4x74.1

P/S

2.9x59.2

Div Yield

0.2%1.8

Momentum

52W High %

54%27.6

RS 6M

—N/A

SMA 50/200

0.87x29.4

EPS Rev 4W

+1.2%51.7

EPS Rev 12W

+1.3%67.5

EPS Improve

+1369%98.7

Q Growth

-61%7.6

FUNDAMENTALS

Market Cap

$4.8B

P/E (Forward)

7.1x

Gross Margin

78.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000661.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
000661.SZ	Changchun High-Tech Industry (Group) Co., Ltd.(you)	$4.8B	34	Sell
002294.SZ	Shenzhen Salubris Pharmaceuticals Co., Ltd.	$5.3B	30	Sell
600521.SS	Zhejiang Huahai Pharmaceutical Co., Ltd.	$3.7B	32	Sell
300199.SZ	Hybio Pharmaceutical Co., Ltd.	$3.1B	37	Hold
002317.SZ	Guangdong Zhongsheng Pharmaceutical Co., Ltd.	$3.2B	38	Hold
600518.SS	Kangmei Pharmaceutical Co., Ltd.	$2.8B	30	Sell
688131.SS	Shanghai Haoyuan Chemexpress Co., Ltd.	$3.1B	41	Hold
300558.SZ	Betta Pharmaceuticals Co., Ltd.	$3.1B	44	Hold
600196.SS	Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	$9.1B	42	Hold
300723.SZ	ApicHope Pharmaceutical Group Co., Ltd.	$2.4B	28	Sell

Peer medians: ROE 4.5% · P/E 29.0x · Gross margin 52.6%

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ): Stock Score Summary

Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) has a MoatMap StockRank of 34/100 based on Quality (50/100), Value (32/100), and Momentum (40/100) factor scores. The current signal is SELL.

Key Financial Metrics

Price	$11.41
Market Cap	$4.8B
P/E (Forward)	7.11
Price/Book	1.41
Return on Equity	-2.0%
Return on Invested Capital	0.2%
Debt/Equity	0.09x
Gross Margin	78.8%
Operating Margin	13.0%
Revenue Growth	-18.0%
Dividend Yield	0.2%
Free Cash Flow	$-206M

Changchun High-Tech Industry (Group) Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Changchun High-Tech Industry (Group) Co., Ltd.’s (000661.SZ) StockRank?: MoatMap’s StockRank for Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) is 34/100, with a Sell signal. It is a composite of Quality (50), Value (32), and Momentum (40) factor ranks across MoatMap’s 20,000+ stock universe.
Does Changchun High-Tech Industry (Group) Co., Ltd. have an economic moat?: Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Changchun High-Tech Industry (Group) Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) is Sell, based on a StockRank of 34/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Changchun High-Tech Industry (Group) Co., Ltd. in?: Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).